English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 88 Help

Selected(0)Clear Items/Page:    Sort:
Guiding induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma with ternary classification of predicted individual treatment effect Journal article
Zhiying Liang, Kit Ian Kou, Chao Luo, Shuqi Li, Yuliang Zhu, Wenjie Huang, Di Cao, Yifei Liu, Guangying Ruan, Shaobo Liang, Xi Chen, Guoyi Zhang, Lizhi Liu, Haojiang Li. Guiding induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma with ternary classification of predicted individual treatment effect[J]. Radiotherapy and Oncology, 2024, 201, 110571.
Authors:  Zhiying Liang;  Kit Ian Kou;  Chao Luo;  Shuqi Li;  Yuliang Zhu; et al.
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.9/5.4 | Submit date：2024/10/16
Nasopharyngeal Carcinoma  Induction Chemotherapy  Overall Survival  Treatment Decision-making  Predicted Individual Treatment Effect  
ABHD5 as a friend or an enemy in cancer biology? Review article
2024
Authors:  Cai, Jianya;  Cheng, Hongwei;  Xu, Shuangta
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.5/4.0 | Submit date：2024/10/10
Abhd5  Invasion  Lipid Metabolism  Oncogene  Proliferation  
HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis Journal article
Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Qiao-Yan Zhu, Yu-Yang Liao, Xiao-Wen Ding, Lin-Feng Zheng, Wen-Ming Cao. HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis[J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16.
Authors:  Pu-Chun Li;  Yi-Fan Zhu;  Jia-Ni Pan;  Qiao-Yan Zhu;  Yu-Yang Liao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.3/4.9 | Submit date：2024/07/08
Brca2  Breast Cancer  Her2-negative  Hormone Receptor-positive  Metastatic Breast Cancer  Prognosis  
Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia Journal article
Mo, Jianshan, Deng, Lin, Peng, Keren, Ouyang, Shumin, Ding, Wen, Lou, Linlin, Lin, Ziyou, Zhu, Jianzheng, Li, Jingwei, Zhang, Qiyi, Wang, Pengyan, Wen, Yuanzhen, Chen, Xiaobing, Yue, Peibin, Lu, Jin Jian, Zhu, Kai, Zheng, Yongjiang, Wang, Yuanxiang, Zhang, Xiaolei. Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia[J]. Journal of Hematology & Oncology, 2023, 16(1), 15.
Authors:  Mo, Jianshan;  Deng, Lin;  Peng, Keren;  Ouyang, Shumin;  Ding, Wen; et al.
Favorite | TC[WOS]:15 TC[Scopus]:14  IF:29.5/26.9 | Submit date：2023/03/06
Aml  Immunotherapy  Stat3 Inhibitor  Vista  
A Rulefit-based prognostic analysis using structured MRI report to select potential beneficiaries from induction chemotherapy in advanced nasopharyngeal carcinoma: A dual-centre study Journal article
Li, Shuqi, Zhang, Weijing, Liang, Baodan, Huang, Wenjie, Luo, Chao, Zhu, Yuliang, Kou, Kit Ian, Ruan, Guangying, Liu, Lizhi, Zhang, Guoyi, Li, Haojiang. A Rulefit-based prognostic analysis using structured MRI report to select potential beneficiaries from induction chemotherapy in advanced nasopharyngeal carcinoma: A dual-centre study[J]. Radiotherapy and Oncology, 2023, 189, 109943.
Authors:  Li, Shuqi;  Zhang, Weijing;  Liang, Baodan;  Huang, Wenjie;  Luo, Chao; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:4.9/5.4 | Submit date：2024/01/02
Induction Chemotherapy  Magnetic Resonance Imaging  Nasopharyngeal Carcinoma  Nomogram  Rulefit  
USP7 reduces the level of nuclear DICER, impairing DNA damage response and promoting cancer progression Journal article
Liu Xiaojia, Lu Runhui, Yang Qianqian, XIE Ruiyu, Zhao Xian, YU Xianxiu. USP7 reduces the level of nuclear DICER, impairing DNA damage response and promoting cancer progression[J]. Molecular Oncology, 2023, 18(1), 170-189.
Authors:  Liu Xiaojia;  Lu Runhui;  Yang Qianqian;  XIE Ruiyu;  Zhao Xian; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:5.0/6.5 | Submit date：2023/12/29
Cancer Progression  Dicer  Mdm2  Ubiquitination  Usp7  
Editorial: Therapeutic antibody domains against cancer Other
2023-08-28
Authors:  Zhao, Qi;  Li, Wei;  Dimitrov, Dimiter S.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2023/08/30
Antibody Domain  Bispecific Antibody  Cancer  Immune Checkpoint  Monoclonal Antibody  Phage Display  
A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov Journal article
Yang, Jing, Kang, Heming, Lyu, Liyang, Xiong, Wei, Hu, Yuanjia. A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov[J]. Discover Oncology, 2023, 14(1), 151.
Authors:  Yang, Jing;  Kang, Heming;  Lyu, Liyang;  Xiong, Wei;  Hu, Yuanjia
Favorite | TC[WOS]:7 TC[Scopus]:7 | Submit date：2023/09/21
Bispecific Antibodies  Combination Therapy  Immuno-oncology Therapy  Kinase Inhibitors  Pd-1/pd-l1 Inhibitors  Targeted Therapy  
Corrigendum to “Factors associated with early mobilization among colorectal cancer patients after surgery: A cross-sectional study. [Eur. J. Oncol. Nurs. 64C (2023) 102317]” (European Journal of Oncology Nursing (2023) 64, (S1462388923000510), (10.1016/j.ejon.2023.102317)) Other
2023-08-20
Authors:  Xie, Jingyue;  Luo, Chuqing;  Du, Qianqian;  Zou, Wenjie;  Li, Xinxin; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2023/11/01
Identification of glycogen phosphorylase L as a potential target for lung cancer Journal article
He,Xin Ling, Lyu,Wen Yu, Li,Xin Yuan, Zhao,Hong, Qi,Lu, Lu,Jin Jian. Identification of glycogen phosphorylase L as a potential target for lung cancer[J]. Medical Oncology, 2023, 40(7), 211.
Authors:  He,Xin Ling;  Lyu,Wen Yu;  Li,Xin Yuan;  Zhao,Hong;  Qi,Lu; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:2.8/2.7 | Submit date：2023/08/03
Glycogen Phosphorylase  Lung Cancer  Mitosis  Pygl  Target  Traditional Chinese Medicine